ABSTRACT
OBJECTIVE:To provide reference for strengthening drug advertisement supervision in departments of food and drug administration. METHODS:The annual statistical reports were collected from departments of food and drug administration during 2006-2016,and the level of province data of Statistical Yearbook of China Food and Drug Administration were also collected in 2013 and 2015. Comparative analysis and quantitative analysis were used to analyze drug advertising approval, revocation of drug advertisement registration approved number,disclosing illegal drug advertisements to industrial and commercial administrative departments and off-site record of drug advertising. RESULTS & CONCLUSIONS:The number of national drug advertising approval decreased from 35 530 in 2006 to 30 027 in 2016,and showed a downward trend on the whole except for a small increase in a few years. The number of revocation of national illegal drug advertisement was basically within 100 in most years;but there was a significant difference between provinces(regions,cities). The number of illegal drug advertisement transferred to industrial and commercial administration departments rose first and then declined since 2014;there was great difference in the proportion of illegal drug advertisement in total number of approved advertisement among the provinces(regions, cities). The proportion of the number of off-site record of drug advertisement in the number of drug advertisement approval in 18 provinces(regions,cities)was higher than national average(69.87%)in 2015. Relevant departments are suggested to gradually abolish off-site record system of drug advertisement,establish prefect drug advertisement review in advance system,strengthen cooperation with industrial and commercial administrative departments,refine statistical indexes of drug advertisement approval and examination,and improve drug advertisement supervision gradually.
ABSTRACT
OBJECTIVE: To provide references for the control of drug advertisements in China. METHODS: The reasons accountable for the illegal drug advertisements that failed to be eliminated were investigated thoroughly by summarizing their manifestation patterns, meanwhile some corresponding countermeasures were brought forward. RESULT & CONCLUSION: The department concerned should strengthen the control of drug advertisements, purify drug advertisement market, and prevent the hidden danger of drug safety from happening.
ABSTRACT
The purpose of this study was to compare differences of information provided in Thai drug advertisements (ads) and foreign drug ads. The advertisements included in the study had to have the same generic name in both Thai and foreign ads. Twenty Thai ads were collected from medical companies, hospitals and Thai medical journals. Twenty foreign ads were collected from foreign medical journals such as The Lancet and JAMA published during 2000-2003. Results showed that there were 5 criterion that the same proportion of Thai and foreign Ads provided information: brand name (100%), indication (95%), initial dose (30%), duration of therapy (30%), and the manufacture or importer name (95%). However, there were 9 criteria by which Thai ads provided less information than foreign ads, but there was no statistical significance. The criteria were generic name, formula, adverse drug reaction, contraindication, precaution, package size, legal category, reference and price. The only criterion by which Thai ads provided significantly less information than foreign ads was information on drug interaction (30% vs. 65%; p = 0.028). In addition, there were 3 criteria by which Thai ads provided more information than foreign ads, but were not significant. The information was the pharmacological group of drugs, standard dose and stability. However, there were 3 criteria by which Thai ads provided significantly more information than foreign ads: dosage form (70% vs. 50%; p = 0.046), storage (95% vs. 70%; p = 0.046) and administration (25% vs. 0%; p = 0.024). In addition the results showed that most Thai and foreign ads used the alphabet size of 3 mm or more to describe the information on brand name, generic name and indication. However, they used the alphabet size of less than 3 mm to describe the information on formula, standard dose, initial dose, adverse drug reaction, contraindication, precaution, duration of therapy, storage, package size, legal category, administration, drug interaction and reference. Results from the study indicated that there are double standards of information provided in Thai and foreign ads even though the drugs had the same generic names and were manufactured by the same company. Health personnel should use other sources of information, in addition to the information from the ads, to prescribe drugs.